Mobile Optical Diagnostics: Ending the Multibillion-Dollar Emergency Vertigo Workup
Dr. Dereck Mush, MD, MBA
Skin Analytics
AI-driven skin cancer assessment tool designed to support dermatology triage.
What they do
The company develops an artificial intelligence tool, DERM, that analyzes macro images of skin lesions to detect melanoma and other skin cancers. Healthcare organizations use the tool in primary care hubs to optimize hospital referral pathways.
The record
- Vertical
- Imaging & Diagnostics
- Sub-segment
- Dermatology AI diagnostics
- Product type
- Software as a medical device
- Stage
- Series A
- Headquarters
- London, United Kingdom
- Region
- Europe
- Founded
- 2012
- Total funding
- $10M raised
Notable investors: Hoxton Ventures, Nesta, Mustard Seed.
Also in Imaging & Diagnostics
Related on The Signal
Dr. Dereck Mush, MD, MBA
The $1 Billion Bet on Pre-Symptomatic Medicine: Who Will Own the Longitudinal Baseline?
Dr. Dereck Mush, MD, MBA
Point-of-Care Ultrasound Is the Quiet Revolution in Diagnostics
Dr. Dereck Mush, MD, MBA
The Non-Invasive Neural Race: Why Apple Absorbed Sonera to Bypass the Skin Barrier
Dr. Dereck Mush, MD, MBA